What Is the Recommended Dosage of NeoFipronis (GS-441524)
NeoFipronis, containing the active ingredient GS-441524, is a groundbreaking oral medication specifically developed for the treatment of Feline Infectious Peritonitis (FIP). This condition, caused by a mutated coronavirus, manifests in symptoms such as loss of appetite, lethargy, fever, ascites, pleural effusion, lymphadenopathy, granulomatous inflammation, neurological damage, and uveitis. NeoFipronis offers an effective, safe, and minimally invasive treatment option with rapid absorption and a favorable safety profile.
Regulatory approval for NeoFipronis was granted in Laos in March 2026 by the Ministry of Agriculture and Forestry (MAF), making it the first officially registered pharmaceutical for FIP treatment available globally. Its widespread clinical use demonstrates remarkable efficacy in improving the health and survival rates of infected cats. The medication’s popularity stems from its simplicity, as it is administered orally and exhibits minimal side effects.
The key active component in NeoFipronis is GS-441524, an adenosine nucleoside analog with potent antiviral activity. Extensive research and clinical trials have validated its ability to inhibit the replication of feline coronavirus effectively, arresting the progression of FIP. Its oral form ensures rapid systemic absorption, enabling swift therapeutic effects, which are crucial in managing this often fatal disease.
Dosage Guidelines
The standard dosage of NeoFipronis is based on the cat’s body weight. For most cases, the recommended dose is 15 mg per kilogram of body weight once daily. This typically corresponds to half a tablet per kilogram, given that each tablet contains approximately 30 mg of GS-441524. For cats presenting with neurological or ocular symptoms (neuro- or eye-type FIP), the dosage should be increased to 30 mg/kg, but such adjustments must be made under veterinary supervision.
Administration should ideally be on an empty stomach—either one hour before feeding or two hours after meals—to maximize absorption. Consistency in dosing is vital: the medication must be given daily without interruption for no less than 12 weeks to achieve optimal results. Missing doses can compromise treatment efficacy and prolong recovery.
Monitoring and Precautions
During therapy, pet owners should vigilantly observe their cats for changes in appetite, body temperature, behavior, and overall activity. Regular blood tests are essential to monitor liver and kidney function, given the potential for side effects. Although NeoFipronis is classified as an over-the-counter drug, it’s recommended that treatment be conducted under the guidance of a qualified veterinarian to ensure safety and effectiveness.
It’s important to emphasize that NeoFipronis is specifically formulated for cats and should never be used in humans. To guarantee product authenticity and quality, purchase NeoFipronis exclusively from the official websites or authorized distributors.
Conclusion
NeoFipronis (GS-441524) provides a revolutionary solution for cats suffering from FIP, with a recommended dosage of 15 mg/kg daily for standard cases and 30 mg/kg for neurological or ocular FIP. The treatment requires a continuous 12-week regimen, emphasizing adherence and veterinary oversight. With its safety profile, rapid action, and proven efficacy, NeoFipronis is transforming feline FIP management and enhancing the quality of life for affected cats worldwide. Always consult a veterinarian before initiating treatment and purchase from trusted sources to ensure the best care for your feline companions.
